Differential regulation of the glutamate transporter variants GLT-1a and GLT-1b in the cortex and spinal cord of transgenic rats expressing hSOD1 G93A

Neurochemistry International

Volumn 63, Issue 2, 2013, Pages 61-68

  Dumont, Amélie O ^a   Hermans, Emmanuel ^a   Goursaud, Stéphanie ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Amyotrophic lateral sclerosis; EAAC1; GLAST; GLT 1a; GLT 1b; Transgenic rat model

Indexed keywords

COMPLEMENTARY DNA; COPPER ZINC SUPEROXIDE DISMUTASE; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMATE TRANSPORTER; MESSENGER RNA; SODIUM GLUCOSE COTRANSPORTER 1A; SODIUM GLUCOSE COTRANSPORTER 2B; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; GENOTYPE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD; SYMPTOM; TRANSGENIC RAT; WILD TYPE;

ANIMALIA; RATTUS;

EID: 84878270733     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.04.012     Document Type: Article

References (56)

1. Aoki, M., Kato, S., Nagai, M., Itoyama, Y., 2005. Development of a rat model of amyotrophic lateral sclerosis expressing a human SOD1 transgene. Neuropathology 25, 365-370. (Pubitemid 43943247)
2. Barbeito, L.H., Pehar, M., Cassina, P., Vargas, M.R., Peluffo, H., Viera, L., Estevez, A.G., Beckman, J.S., 2004. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res. Brain Res. Rev. 47, 263-274. (Pubitemid 39574324)
3. Barber, S.C., Shaw, P.J., 2010. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic. Biol. Med. 48, 629-641.
4. Bassan, M., Liu, H., Madsen, K.L., Armsen, W., Zhou, J., Desilva, T., Chen, W., Paradise, A., Brasch, M.A., Staudinger, J., Gether, U., Irwin, N., Rosenberg, P.A., 2008. Interaction between the glutamate transporter GLT1b and the synaptic PDZ domain protein PICK1. Eur. J. Neurosci. 27, 66-82.
5. Beart, P.M., O'Shea, R.D., 2007. Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement. Br. J. Pharmacol. 150, 5-17. (Pubitemid 46094664)
6. Bendotti, C., Tortarolo, M., Suchak, S.K., Calvaresi, N., Carvelli, L., Bastone, A., Rizzi, M., Rattray, M., Mennini, T., 2001. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J. Neurochem. 79, 737-746. (Pubitemid 33086511)
7. Berger, J.V., Deumens, R., Goursaud, S., Schafer, S., Lavand'homme, P., Joosten, E.A., Hermans, E., 2011. Enhanced neuroinflammation and pain hypersensitivity after peripheral nerve injury in rats expressing mutated superoxide dismutase 1. J. Neuroinflamm. 8, 33.
8. Boston-Howes, W., Gibb, S.L., Williams, E.O., Pasinelli, P., Brown Jr., R.H., Trotti, D., 2006. Caspase-3 cleaves and inactivates the glutamate transporter EAAT2. J. Biol. Chem. 281, 14076-14084. (Pubitemid 43848334)
9. Bristol, L.A., Rothstein, J.D., 1996. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Ann. Neurol. 39, 676-679. (Pubitemid 26143607)
10. Canton, T., Pratt, J., Stutzmann, J.M., Imperato, A., Boireau, A., 1998. Glutamate uptake is decreased tardively in the spinal cord of FALS mice. Neuroreport 9, 775-778. (Pubitemid 28179273)
11. Chen, W., Aoki, C., Mahadomrongkul, V., Gruber, C.E., Wang, G.J., Blitzblau, R., Irwin, N., Rosenberg, P.A., 2002. Expression of a variant form of the glutamate transporter GLT1 in neuronal cultures and in neurons and astrocytes in the rat brain. J. Neurosci. 22, 2142-2152. (Pubitemid 35386514)
12. Danbolt, N.C., 2001. Glutamate uptake. Prog. Neurobiol. 65, 1-105. (Pubitemid 32479155)
13. Deitch, J.S., Alexander, G.M., Del Valle, L., Heiman-Patterson, T.D., 2002. GLT-1 glutamate transporter levels are unchanged in mice expressing G93A human mutant SOD1. J. Neurol. Sci. 193, 117-126. (Pubitemid 34098943)
14. Dracheva, S., Elhakem, S.L., Marcus, S.M., Siever, L.J., McGurk, S.R., Haroutunian, V., 2003. RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia. J. Neurochem. 87, 1402-1412. (Pubitemid 38020574)
15. Dunlop, J., Beal, M.H., She, Y., Howland, D.S., 2003. Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis. J. Neurosci. 23, 1688-1696. (Pubitemid 36314724)
16. Elliott, J.L., 2001. Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res. Mol. Brain Res. 95, 172-178. (Pubitemid 33000377)
17. Ferraiuolo, L., Kirby, J., Grierson, A.J., Sendtner, M., Shaw, P.J., 2011. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 7, 616-630.
18. Foerster, B.R., Callaghan, B.C., Petrou, M., Edden, R.A., Chenevert, T.L., Feldman, E.L., 2012. Decreased motor cortex gamma-aminobutyric acid in amyotrophic lateral sclerosis. Neurology 78, 1596-1600.
19. Garcia-Tardon, N., Gonzalez-Gonzalez, I.M., Martinez-Villarreal, J., Fernandez- Sanchez, E., Gimenez, C., Zafra, F., 2012. Protein kinase C (PKC)-promoted endocytosis of glutamate transporter GLT-1 requires ubiquitin ligase Nedd4-2- dependent ubiquitination but not phosphorylation. J. Biol. Chem. 287, 19177- 19187.
20. Gonzalez-Gonzalez, I.M., Garcia-Tardon, N., Gimenez, C., Zafra, F., 2009. Splice variants of the glutamate transporter GLT1 form hetero-oligomers that interact with PSD-95 and NMDA receptors. J. Neurochem. 110, 264-274.
21. Goursaud, S., Focant, M.C., Berger, J.V., Nizet, Y., Maloteaux, J.M., Hermans, E., 2011. The VPAC2 agonist peptide histidine isoleucine (PHI) up-regulates glutamate transport in the corpus callosum of a rat model of amyotrophic lateral sclerosis (hSOD1G93A) by inhibiting caspase-3 mediated inactivation of GLT-1a. FASEB J. 25, 3674-3686.
22. Goursaud, S., Maloteaux, J.M., Hermans, E., 2009. Distinct expression and regulation of the glutamate transporter isoforms GLT-1a and GLT-1b in cultured astrocytes from a rat model of amyotrophic lateral sclerosis (hSOD1G93A). Neurochem. Int. 55, 28-34.
23. Guillet, B.A., Velly, L.J., Canolle, B., Masmejean, F.M., Nieoullon, A.L., Pisano, P., 2005. Differential regulation by protein kinases of activity and cell surface expression of glutamate transporters in neuron-enriched cultures. Neurochem. Int. 46, 337-346. (Pubitemid 40221847)
24. Holmseth, S., Dehnes, Y., Huang, Y.H., Follin-Arbelet, V.V., Grutle, N.J., Mylonakou, M.N., Plachez, C., Zhou, Y., Furness, D.N., Bergles, D.E., Lehre, K.P., Danbolt, N.C., 2012. The density of EAAC1 (EAAT3) glutamate transporters expressed by neurons in the mammalian CNS. J. Neurosci. 32, 6000-6013.
25. Holmseth, S., Scott, H.A., Real, K., Lehre, K.P., Leergaard, T.B., Bjaalie, J.G., Danbolt, N.C., 2009. The concentrations and distributions of three C-terminal variants of the GLT1 (EAAT2; slc1a2) glutamate transporter protein in rat brain tissue suggest differential regulation. Neuroscience 162, 1055-1071.
26. Howland, D.S., Liu, J., She, Y., Goad, B., Maragakis, N.J., Kim, B., Erickson, J., Kulik, J., DeVito, L., Psaltis, G., DeGennaro, L.J., Cleveland, D.W., Rothstein, J.D., 2002. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc. Natl. Acad. Sci. USA 99, 1604-1609. (Pubitemid 34136539)
27. Jensen, A.A., Brauner-Osborne, H., 2004. Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescencebased membrane potential assay. Biochem. Pharmacol. 67, 2115-2127. (Pubitemid 38595492)
28. Kalandadze, A., Wu, Y., Robinson, M.B., 2002. Protein kinase C activation decreases cell surface expression of the GLT-1 subtype of glutamate transporter. Requirement of a carboxyl-terminal domain and partial dependence on serine 486. J. Biol. Chem. 277, 45741-45750. (Pubitemid 35417550)
29. Lau, A., Tymianski, M., 2010. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch. 460, 525-542.
30. Lauriat, T.L., McInnes, L.A., 2007. EAAT2 regulation and splicing: relevance to psychiatric and neurological disorders. Mol. Psychiatry 12, 1065-1078. (Pubitemid 350191362)
31. Maragakis, N.J., Dykes-Hoberg, M., Rothstein, J.D., 2004. Altered expression of the glutamate transporter EAAT2b in neurological disease. Ann. Neurol. 55, 469- 477. (Pubitemid 38391963)
32. Matsumoto, A., Okada, Y., Nakamichi, M., Nakamura, M., Toyama, Y., Sobue, G., Nagai, M., Aoki, M., Itoyama, Y., Okano, H., 2006. Disease progression of human SOD1 (G93A) transgenic ALS model rats. J. Neurosci. Res. 83, 119-133. (Pubitemid 43062016)
33. Meyer, T., Fromm, A., Munch, C., Schwalenstocker, B., Fray, A.E., Ince, P.G., Stamm, S., Gron, G., Ludolph, A.C., Shaw, P.J., 1999. The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals. J. Neurol. Sci. 170, 45-50. (Pubitemid 29502534)
34. Munch, C., Ebstein, M., Seefried, U., Zhu, B., Stamm, S., Landwehrmeyer, G.B., Ludolph, A.C., Schwalenstocker, B., Meyer, T., 2002. Alternative splicing of the 50-sequences of the mouse EAAT2 glutamate transporter and expression in a transgenic model for amyotrophic lateral sclerosis. J. Neurochem. 82, 594-603. (Pubitemid 34831497)
35. Nagai, M., Aoki, M., Miyoshi, I., Kato, M., Pasinelli, P., Kasai, N., Brown Jr., R.H., Itoyama, Y., 2001. Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J. Neurosci. 21, 9246-9254. (Pubitemid 33096868)
36. Peacey, E., Miller, C.C., Dunlop, J., Rattray, M., 2009. The four major N- and Cterminal splice variants of the excitatory amino acid transporter GLT-1 form cell surface homomeric and heteromeric assemblies. Mol. Pharmacol. 75, 1062- 1073.
37. Raghavendra Rao, V., Rao, A.M., Dogan, A., Bowen, K.K., Hatcher, J., Rothstein, J.D., Dempsey, R.J., 2000. Glial glutamate transporter GLT-1 down-regulation precedes delayed neuronal death in gerbil hippocampus following transient global cerebral ischemia. Neurochem. Int. 36, 531-537. (Pubitemid 30101565)
38. Raymond, M., Li, P., Mangin, J.M., Huntsman, M., Gallo, V., 2011. Chronic perinatal hypoxia reduces glutamate-aspartate transporter function in astrocytes through the Janus kinase/signal transducer and activator of transcription pathway. J. Neurosci. 31, 17864-17871.
39. Regan, M.R., Huang, Y.H., Kim, Y.S., Dykes-Hoberg, M.I., Jin, L., Watkins, A.M., Bergles, D.E., Rothstein, J.D., 2007. Variations in promoter activity reveal a differential expression and physiology of glutamate transporters by glia in the developing and mature CNS. J. Neurosci. 27, 6607-6619. (Pubitemid 46983424)
40. Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J.P., Deng, H.X., 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62. (Pubitemid 23087289)
41. Rothstein, J.D., 2009. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann. Neurol. 65 (Suppl. 1), S3-S9.
42. Rothstein, J.D., Dykes-Hoberg, M., Pardo, C.A., Bristol, L.A., Jin, L., Kuncl, R.W., Kanai, Y., Hediger, M.A., Wang, Y., Schielke, J.P., Welty, D.F., 1996. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 675-686. (Pubitemid 26103145)
43. Rothstein, J.D., Martin, L.J., Kuncl, R.W., 1992. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326, 1464-1468.
44. Rothstein, J.D., Van Kammen, M., Levey, A.I., Martin, L.J., Kuncl, R.W., 1995. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38, 73-84.
45. Sasabe, J., Aiso, S., 2010. Aberrant control of motoneuronal excitability in amyotrophic lateral sclerosis: excitatory glutamate/D-serine vs. inhibitory glycine/gamma-aminobutanoic acid (GABA). Chem. Biodivers. 7, 1479-1490.
46. Schafer, S., Hermans, E., 2011. Reassessment of motor-behavioural test analyses enables the detection of early disease-onset in a transgenic mouse model of amyotrophic lateral sclerosis. Behav. Brain Res. 225, 7-14.
47. Scott, H.A., Gebhardt, F.M., Mitrovic, A.D., Vandenberg, R.J., Dodd, P.R., 2011. Glutamate transporter variants reduce glutamate uptake in Alzheimer's disease. Neurobiol. Aging 32, 511-553.
48. Sheldon, A.L., Gonzalez, M.I., Krizman-Genda, E.N., Susarla, B.T., Robinson, M.B., 2008. Ubiquitination-mediated internalization and degradation of the astroglial glutamate transporter, GLT-1. Neurochem. Int. 53, 296-308.
49. Sheldon, A.L., Robinson, M.B., 2007. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem. Int. 51, 333-355. (Pubitemid 47503456)
50. Sullivan, R., Rauen, T., Fischer, F., Wiessner, M., Grewer, C., Bicho, A., Pow, D.V., 2004. Cloning, transport properties, and differential localization of two splice variants of GLT-1 in the rat CNS: implications for CNS glutamate homeostasis. Glia 45, 155-169. (Pubitemid 38196992)
51. Turner, B.J., Talbot, K., 2008. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog. Neurobiol. 85, 94-134.
52. Vermeiren, C., Hemptinne, I., Vanhoutte, N., Tilleux, S., Maloteaux, J.M., Hermans, E., 2006. Loss of metabotropic glutamate receptor-mediated regulation of glutamate transport in chemically activated astrocytes in a rat model of amyotrophic lateral sclerosis. J. Neurochem. 96, 719-731.
53. Warita, H., Manabe, Y., Murakami, T., Shiote, M., Shiro, Y., Hayashi, T., Nagano, I., Shoji, M., Abe, K., 2002. Tardive decrease of astrocytic glutamate transporter protein in transgenic mice with ALS-linked mutant SOD1. Neurol. Res. 24, 577- 581. (Pubitemid 35024486)
54. Wijesekera, L.C., Leigh, P.N., 2009. Amyotrophic lateral sclerosis. Orphanet. J. Rare. Dis. 4, 3.
55. Yoshihara, T., Ishigaki, S., Yamamoto, M., Liang, Y., Niwa, J., Takeuchi, H., Doyu, M., Sobue, G., 2002. Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 80, 158-167. (Pubitemid 34614588)
56. Zelenaia, O.A., Robinson, M.B., 2000. Degradation of glial glutamate transporter mRNAs is selectively blocked by inhibition of cellular transcription. J. Neurochem. 75, 2252-2258.